Trials / Unknown
UnknownNCT05490576
Tau And Connectomics In TES Study
Pilot Phase 1 Clinical Trial of PET Scanning in Tau Protein Deposition and Connectome Analysis in Traumatic Encephalopathy Syndrome (TES) Cohort With a Probable Chronic Traumatic Encephalopathy (CTE) Pattern of Neurodegenerative Disease
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Macquarie University, Australia · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This pilot study aims to assess if participants that meet the criteria for a TES diagnosis have a specific tau deposition profile on PET scanning using the PET tau binding ligand - \[18F\] PI-2620. It is hoped this study will highlight potential diagnostic tests of TES diagnosis, the in-life correlate of CTE.
Conditions
- Chronic Traumatic Encephalopathy
- Traumatic Encephalopathy
- Head Injury Trauma
- Cognitive Impairment
- Neurodegenerative Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | [18F] PI-2620 Tau Ligand | Tau binding ligand |
Timeline
- Start date
- 2023-02-03
- Primary completion
- 2023-05-30
- Completion
- 2024-12-31
- First posted
- 2022-08-05
- Last updated
- 2024-02-28
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05490576. Inclusion in this directory is not an endorsement.